Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline

Go back to Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
Merck & Co. (NYSE: MRK) Delayed: 130.42 -0.5 (0.38%)
Previous Close $130.92    52 Week High $65.46 
Open $129.93    52 Week Low $47.97 
Day High $132.84    P/E 88.72 
Day Low $129.70    EPS $1.47 
Volume 6,343,840